Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study

Introduction: Various biomarkers are used when evaluating the hospitalization needs of patients diagnosed with Coronavirus disease (COVID-19). Ischemia-modified albumin (IMA) is a biomarker that causes blood levels to increase as a result of hypoxia and acidosis. We think that an increase in IMA in...

Descripción completa

Detalles Bibliográficos
Autores principales: Altintas, Emel, Sabirli, Ramazan, Yuksekkaya, Esra, Kurt, Ozgur, Koseler, Aylin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500556/
https://www.ncbi.nlm.nih.gov/pubmed/36168388
http://dx.doi.org/10.7759/cureus.28334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500556/
https://www.ncbi.nlm.nih.gov/pubmed/36168388
http://dx.doi.org/10.7759/cureus.28334

Ejemplares similares